These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 18160600
1. Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome. de Larrañaga G, Wingeyer SP, Graffigna M, Belli S, Bendezú K, Alvarez S, Levalle O, Fainboim H. Clin Appl Thromb Hemost; 2008 Jul; 14(3):319-24. PubMed ID: 18160600 [Abstract] [Full Text] [Related]
2. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults. Appel SJ, Harrell JS, Davenport ML. J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162 [Abstract] [Full Text] [Related]
3. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Alessi MC, Bastelica D, Mavri A, Morange P, Berthet B, Grino M, Juhan-Vague I. Arterioscler Thromb Vasc Biol; 2003 Jul 01; 23(7):1262-8. PubMed ID: 12750120 [Abstract] [Full Text] [Related]
4. The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease. Ades PA, Savage PD, Toth MJ, Schneider DJ, Audelin MC, Bunn JY, Ludlow M. Int J Obes (Lond); 2008 Jun 01; 32(6):967-74. PubMed ID: 18268512 [Abstract] [Full Text] [Related]
8. Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients. Kitagawa N, Yano Y, Gabazza EC, Bruno NE, Araki R, Matsumoto K, Katsuki A, Hori Y, Nakatani K, Taguchi O, Sumida Y, Suzuki K, Adachi Y. Diabetes Res Clin Pract; 2006 Aug 01; 73(2):150-7. PubMed ID: 16458385 [Abstract] [Full Text] [Related]
9. Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Verrijken A, Francque S, Mertens I, Prawitt J, Caron S, Hubens G, Van Marck E, Staels B, Michielsen P, Van Gaal L. Hepatology; 2014 Jan 01; 59(1):121-9. PubMed ID: 24375485 [Abstract] [Full Text] [Related]
10. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults. Sung KC, Ryan MC, Kim BS, Cho YK, Kim BI, Reaven GM. Diabetes Care; 2007 Aug 01; 30(8):2113-8. PubMed ID: 17475935 [Abstract] [Full Text] [Related]
11. Association between abnormal liver function and risk factors for metabolic syndrome among freshmen. Tsai PY, Yen CJ, Li YC, Chiu TY, Chen CY, Jan CF. J Adolesc Health; 2007 Aug 01; 41(2):132-7. PubMed ID: 17659216 [Abstract] [Full Text] [Related]
12. [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?]. Graffigna MN, Belli SH, de Larrañaga G, Fainboim H, Estepo C, Peres S, García N, Levalle O. Acta Gastroenterol Latinoam; 2009 Mar 01; 39(1):30-7. PubMed ID: 19408737 [Abstract] [Full Text] [Related]
19. Relationship between insulin resistance and some coagulation and fibrinolytic parameters in patients with metabolic syndrome. Ragab A, Abousamra NK, Higazy A, Saleh O. Lab Hematol; 2008 Aug 01; 14(1):1-6. PubMed ID: 18403313 [Abstract] [Full Text] [Related]
20. High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects. Vilar L, Oliveira CP, Faintuch J, Mello ES, Nogueira MA, Santos TE, Alves VA, Carrilho FJ. Nutrition; 2008 Aug 01; 24(11-12):1097-102. PubMed ID: 18640006 [Abstract] [Full Text] [Related] Page: [Next] [New Search]